Correlation Between Vincerx Pharma and Rani Therapeutics

Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vincerx Pharma and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Vincerx Pharma and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Rani Therapeutics.

Diversification Opportunities for Vincerx Pharma and Rani Therapeutics

0.38

Correlation Coefficient

Vincerx Pharma  Rani Therapeutics

Weak diversification

The 3 months correlation between Vincerx and Rani is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Rani Therapeutics go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Rani Therapeutics

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Rani Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vincerx Pharma is 1.5 times less risky than Rani Therapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The Rani Therapeutics Holdings is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  296.00  in Rani Therapeutics Holdings on August 31, 2024 and sell it today you would lose (97.00) from holding Rani Therapeutics Holdings or give up 32.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Vincerx Pharma  vs.  Rani Therapeutics Holdings

Vincerx Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Rani Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rani Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Vincerx Pharma and Rani Therapeutics

The main advantage of trading using opposite Vincerx Pharma and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.

The idea behind Vincerx Pharma and Rani Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.